Table I.
[3H]AA release (relative units; basal release = 1) (n = 3)
|
||
---|---|---|
Treatment | BK | BK + thrombin |
Vehicle | 6.8 ± 0.8 | 11.8 ± 0.7 |
Tyr kinase inhibitor genistein 100 μM | 6.8 ± 0.4 | 11.6 ± 0.6 |
PKG inhib. 0.5 μM (RQIKIWFQNRRMKWKKLRKKKKH) | 6.7 ± 0.3 | 11.7 ± 0.5 |
PKA inhib. 0.5 μM (H-89, dihydrochloride) | 8.6 ± 0.4 | 11.7 ± 0.5 |
IP3 kinase inhibitor wortmannin 0.5 μM | 6.5 ± 0.6 | 11.3 ± 0.9 |
Methyl-β-cyclodextrin 5 mM | 6.9 ± 0.6 | 12.0 ± 0.8 |